secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001558370-24-008446
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EC rejects CHMP negative opinion on Translarna; returns for re-evaluation; 2024 guidance paused
--------------------------------------------------------------------------------

- EC decided not to adopt CHMP's negative opinion for Translarna annual renewal; returns to CHMP for re-evaluation.
- Translarna remains authorized and available in Europe; EC asks CHMP to consider real-world evidence.
- PTC pauses 2024 total revenue guidance due to uncertainty from continued Translarna authorization upside.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000155837024008446/0001558370-24-008446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000155837024008446/tmb-20240520x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer